Products & Solutions

AI-Powered Retinal Screening for Early Disease Detection

RetinaX.ai is at the forefront of AI-driven retinal imaging, providing autonomous and scalable screening solutions for diabetic retinopathy (DR) and other vision-threatening diseases. Our advanced deep learning algorithms analyze high-resolution retinal images in real time, enabling optometrists, general practitioners, and pharmacists to detect ocular and systemic diseases with unprecedented accuracy and efficiency.

Our Key Offerings:

• AI-Based Diabetic Retinopathy Screening – Fast, accurate, and FDA-compliant autonomous DR detection.
• Multi-Disease Retinal Analysis – Ongoing development of AI models to identify AMD, glaucoma, hypertensive retinopathy, and cardiovascular risk markers.
• Seamless Integration – Works with cost-effective, high-quality retinal imaging devices to bring AI-powered diagnostics to primary care, pharmacies, and home monitoring.